{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:04:08Z","timestamp":1779372248876,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["2021-KYYWF-0254"],"award-info":[{"award-number":["2021-KYYWF-0254"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["JJQN2021\u201304"],"award-info":[{"award-number":["JJQN2021\u201304"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Circular RNAs (circRNAs) play critical regulatory roles in cancer biological processes. Nevertheless, the contributions and underlying mechanisms of circRNAs to pancreatic ductal adenocarcinoma (PDAC) remain largely unexplored. Dysregulated circRNAs between cancerous tissues and matched adjacent normal tissues were identified by circRNA microarray in PDAC. The biological effect of hsa_circ_007367 both in vitro and in vivo was demonstrated by gain- and loss-of-function experiments. Further, dual-luciferase reporter and RNA pull-down assays were performed to confirm the interaction among hsa_circ_007367, miR-6820-3p, and Yes-associated protein 1 (YAP1). The expression of hsa_circ_007367 and YAP1 were detected by in situ hybridization (ISH) and immunohistochemistry (IHC) using tissue microarray (TMA) in 128 PDAC samples. We first identified that a novel circRNA, hsa_circ_0007367, was markedly upregulated in PDAC tissues and cells. Functionally, in vivo and in vitro data indicated that hsa_circ_0007367 promotes the proliferation and metastasis of PDAC. Mechanistically, we confirmed that hsa_circ_0007367 could facilitate the expression of YAP1, a well-known oncogene, by sponging miR-6820-3p, which function as a tumor suppresser in PDAC cells. The results of ISH and IHC demonstrated that hsa_circ_0007367 and YAP1 were upregulated in PDAC tissues. Furthermore, clinical data showed that higher hsa_circ_0007367 expression was correlated with advanced histological grade and lymph node metastasis in PDAC patients. In conclusion, our findings reveal that hsa_circ_0007367 acts as an oncogene via modulating miR-6820-3p\/YAP1 axis to promote the progression of PDAC, and suggest that hsa_circ_0007367 may serve as a potential therapeutic target for treatment of PDAC.<\/jats:p>","DOI":"10.1038\/s41419-022-05188-8","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T13:02:37Z","timestamp":1661432557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Circular RNA hsa_circ_0007367 promotes the progression of pancreatic ductal adenocarcinoma by sponging miR-6820-3p and upregulating YAP1 expression"],"prefix":"10.1038","volume":"13","author":[{"given":"Haocheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruipu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0235-5916","authenticated-orcid":false,"given":"Guofen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"5188_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"5188_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.pan.2020.02.011","volume":"20","author":"X Chen","year":"2020","unstructured":"Chen X, Yi B, Liu Z, Zou H, Zhou J, Zhang Z, et al. Global, regional and national burden of pancreatic cancer, 1990 to 2017: results from the Global Burden of Disease Study 2017. Pancreatology. 2020;20:462\u20139.","journal-title":"Pancreatology"},{"key":"5188_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388:73\u201385.","journal-title":"Lancet"},{"key":"5188_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jso.24623","volume":"116","author":"R Gupta","year":"2017","unstructured":"Gupta R, Amanam I, Chung V. Current and future therapies for advanced pancreatic cancer. J Surg Oncol. 2017;116:25\u201334.","journal-title":"J Surg Oncol"},{"key":"5188_CR5","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi AD, Koay EJ, Chari ST, Maitra A. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology 2019;156:2024\u201340.","journal-title":"Gastroenterology"},{"key":"5188_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, et al. The landscape of circular RNA in cancer. Cell 2019;176:869\u201381. e13","journal-title":"Cell"},{"key":"5188_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013;495:333\u20138.","journal-title":"Nature"},{"key":"5188_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22:256\u201364.","journal-title":"Nat Struct Mol Biol"},{"key":"5188_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature 2013;495:384\u20138.","journal-title":"Nature"},{"key":"5188_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01196-4","volume":"19","author":"X Guo","year":"2020","unstructured":"Guo X, Zhou Q, Su D, Luo Y, Fu Z, Huang L, et al. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p\/MET\/Akt axis. Mol Cancer. 2020;19:83.","journal-title":"Mol Cancer"},{"key":"5188_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.omtn.2019.12.028","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi H, Li H, Zhen T, Dong Y, Pei X, Zhang X. hsa_circ_001653 implicates in the development of pancreatic ductal adenocarcinoma by regulating microRNA-377-mediated HOXC6 axis. Mol Ther Nucleic Acids. 2020;20:252\u201364.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5188_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15:73\u20139.","journal-title":"Nat Rev Cancer"},{"key":"5188_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.1843810","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev. 2010;24:72\u201385.","journal-title":"Genes Dev"},{"key":"5188_CR14","doi-asserted-by":"publisher","first-page":"8517","DOI":"10.1158\/0008-5472.CAN-10-1242","volume":"70","author":"CA Hall","year":"2010","unstructured":"Hall CA, Wang R, Miao J, Oliva E, Shen X, Wheeler T, et al. Hippo pathway effector YAP is an ovarian cancer oncogene. Cancer Res. 2010;70:8517\u201325.","journal-title":"Cancer Res"},{"key":"5188_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/carcin\/bgq254","volume":"32","author":"T Muramatsu","year":"2011","unstructured":"Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, Sudol M, et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 2011;32:389\u201398.","journal-title":"Carcinogenesis"},{"key":"5188_CR16","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1158\/1078-0432.CCR-10-2467","volume":"17","author":"W Kang","year":"2011","unstructured":"Kang W, Tong JH, Chan AW, Lee TL, Lung RW, Leung PP, et al. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res. 2011;17:2130\u20139.","journal-title":"Clin Cancer Res"},{"key":"5188_CR17","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1261\/rna.043687.113","volume":"20","author":"P Glazar","year":"2014","unstructured":"Glazar P, Papavasileiou P, Rajewsky N. circBase: a database for circular RNAs. RNA 2014;20:1666\u201370.","journal-title":"RNA"},{"key":"5188_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2230-9","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan Y, et al. circRNA-002178 act as a ceRNA to promote PDL1\/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020;11:32.","journal-title":"Cell Death Dis"},{"key":"5188_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.omtn.2021.05.021","volume":"26","author":"D Jin","year":"2021","unstructured":"Jin D, Huang K, Peng L, Xu P, Dang Y, Yang J, et al. Circular RNA circDNA2 upregulates CCDC6 expression to promote the progression of gastric cancer via miR-149-5p suppression. Mol Ther Nucleic Acids. 2021;26:360\u201373.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5188_CR20","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2018.01.012","volume":"68","author":"J Yu","year":"2018","unstructured":"Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68:1214\u201327.","journal-title":"J Hepatol"},{"key":"5188_CR21","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1158\/0008-5472.CAN-09-4531","volume":"70","author":"S Yu","year":"2010","unstructured":"Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W, et al. miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res. 2010;70:6015\u201325.","journal-title":"Cancer Res"},{"key":"5188_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jmcb\/mju003","volume":"6","author":"M Rokavec","year":"2014","unstructured":"Rokavec M, Li H, Jiang L, Hermeking H. The p53\/miR-34 axis in development and disease. J Mol Cell Biol. 2014;6:214\u201330.","journal-title":"J Mol Cell Biol"},{"key":"5188_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.canlet.2021.09.033","volume":"522","author":"P Yadav","year":"2021","unstructured":"Yadav P, Sharma P, Sundaram S, Venkatraman G, Bera AK, Karunagaran D. SLC7A11\/xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells. Cancer Lett. 2021;522:211\u201324.","journal-title":"Cancer Lett"},{"key":"5188_CR24","first-page":"831","volume":"176","author":"S Chen","year":"2019","unstructured":"Chen S, Huang V, Xu X, Livingstone J, Soares F, Jeon J, et al. Widespread and functional RNA circularization in localized prostate. Cancer Cell 2019;176:831\u201343. e22","journal-title":"Cancer Cell"},{"key":"5188_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5188_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03743-3","volume":"12","author":"L Verduci","year":"2021","unstructured":"Verduci L, Tarcitano E, Strano S, Yarden Y, Blandino G. CircRNAs: role in human diseases and potential use as biomarkers. Cell Death Dis. 2021;12:468.","journal-title":"Cell Death Dis"},{"key":"5188_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01400-z","volume":"20","author":"Z Rong","year":"2021","unstructured":"Rong Z, Shi S, Tan Z, Xu J, Meng Q, Hua J, et al. Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294\/c-Myc axis. Mol Cancer. 2021;20:106.","journal-title":"Mol Cancer"},{"key":"5188_CR28","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1158\/0008-5472.CAN-19-3268","volume":"80","author":"CH Wong","year":"2020","unstructured":"Wong CH, Lou UK, Li Y, Chan SL, Tong JHM, To KF, et al. CircFOXK2 promotes growth and metastasis of pancreatic ductal adenocarcinoma by complexing with RNA binding proteins and sponging MiR-942. Cancer Res. 2020;80:2138\u201349.","journal-title":"Cancer Res"},{"key":"5188_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41420-021-00512-1","volume":"7","author":"W Jiang","year":"2021","unstructured":"Jiang W, He Y, Ma Z, Zhang Y, Zhang C, Zheng N, et al. hsa_circ_0008234 inhibits the progression of lung adenocarcinoma by sponging miR-574-5p. Cell Death Disco. 2021;7:123.","journal-title":"Cell Death Disco"},{"key":"5188_CR30","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.29270","volume":"66","author":"D Han","year":"2017","unstructured":"Han D, Li J, Wang H, Su X, Hou J, Gu Y, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology 2017;66:1151\u201364.","journal-title":"Hepatology"},{"key":"5188_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1081-4","volume":"18","author":"S Wang","year":"2019","unstructured":"Wang S, Tang D, Wang W, Yang Y, Wu X, Wang L, et al. circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer. Mol Cancer. 2019;18:162.","journal-title":"Mol Cancer"},{"key":"5188_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01332-8","volume":"20","author":"L Wang","year":"2021","unstructured":"Wang L, Zhou Y, Jiang L, Lu L, Dai T, Li A, et al. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K\/AKT pathway. Mol Cancer. 2021;20:43.","journal-title":"Mol Cancer"},{"key":"5188_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2018.09.019","volume":"438","author":"AM Harrandah","year":"2018","unstructured":"Harrandah AM, Mora RA, Chan EKL. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Cancer Lett. 2018;438:126\u201332.","journal-title":"Cancer Lett"},{"key":"5188_CR34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/1878-0261.12468","volume":"13","author":"L Verduci","year":"2019","unstructured":"Verduci L, Strano S, Yarden Y, Blandino G. The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13:669\u201380.","journal-title":"Mol Oncol"},{"key":"5188_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan K-L. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1\u201317.","journal-title":"Genes Dev"},{"key":"5188_CR36","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747\u201361.","journal-title":"Genes Dev"},{"key":"5188_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13045-017-0445-8","volume":"10","author":"M Sun","year":"2017","unstructured":"Sun M, Song H, Wang S, Zhang C, Zheng L, Chen F, et al. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer. J Hematol Oncol. 2017;10:79.","journal-title":"J Hematol Oncol"},{"key":"5188_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-018-0613-5","volume":"11","author":"L Zheng","year":"2018","unstructured":"Zheng L, Xiang C, Li X, Guo Q, Gao L, Ni H, et al. STARD13-correlated ceRNA network-directed inhibition on YAP\/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase\/F-actin signaling. J Hematol Oncol. 2018;11:72.","journal-title":"J Hematol Oncol"},{"key":"5188_CR39","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ccr.2014.04.016","volume":"25","author":"X Feng","year":"2014","unstructured":"Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, et al. Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell. 2014;25:831\u201345.","journal-title":"Cancer Cell"},{"key":"5188_CR40","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","volume":"125","author":"L Zender","year":"2006","unstructured":"Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006;125:1253\u201367.","journal-title":"Cell"},{"key":"5188_CR41","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/onc.2016.288","volume":"36","author":"S Murakami","year":"2017","unstructured":"Murakami S, Shahbazian D, Surana R, Zhang W, Chen H, Graham GT, et al. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. Oncogene 2017;36:1232\u201344.","journal-title":"Oncogene"},{"key":"5188_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2017.05.015","volume":"402","author":"X Zhao","year":"2017","unstructured":"Zhao X, Wang X, Fang L, Lan C, Zheng X, Wang Y, et al. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer. Cancer Lett. 2017;402:61\u201370.","journal-title":"Cancer Lett"},{"key":"5188_CR43","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1053\/j.gastro.2016.05.006","volume":"151","author":"R Gruber","year":"2016","unstructured":"Gruber R, Panayiotou R, Nye E, Spencer-Dene B, Stamp G, Behrens A. YAP1 and TAZ control pancreatic cancer initiation in mice by direct up-regulation of JAK-STAT3 signaling. Gastroenterology 2016;151:526\u201339.","journal-title":"Gastroenterology"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05188-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05188-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05188-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T14:06:53Z","timestamp":1661436413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05188-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["5188"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05188-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research was approved by the Ethics Committee of Harbin Medical University. Written informed consents were obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The publication of this manuscript has been approved by all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"736"}}